The estimated Net Worth of Michael Parini is at least $44.4 Million dollars as of 24 February 2021. Mr. Parini owns over 3,028 units of Vertex Pharmaceuticals stock worth over $14,639,557 and over the last 9 years he sold VRTX stock worth over $24,340,079. In addition, he makes $5,372,340 as Executive Vice President and Chief Legal and Administrative Officer at Vertex Pharmaceuticals.
Michael has made over 61 trades of the Vertex Pharmaceuticals stock since 2017, according to the Form 4 filled with the SEC. Most recently he sold 3,028 units of VRTX stock worth $646,115 on 24 February 2021.
The largest trade he's ever made was selling 40,764 units of Vertex Pharmaceuticals stock on 25 April 2018 worth over $6,493,298. On average, Michael trades about 3,572 units every 22 days since 2016. As of 24 February 2021 he still owns at least 30,837 units of Vertex Pharmaceuticals stock.
You can see the complete history of Mr. Parini stock trades at the bottom of the page.
Michael J. Parini, J.D. is Executive Vice President, Chief Legal and Administrative Officer of the Vertex Pharmaceuticals Incorporated since January 2017. From January 2016 to January 2017, he was our Executive Vice President and Chief Legal Officer. From 2004 until he joined Vertex, Mr. Parini served in various roles of increasing responsibility at Pfizer Inc., a pharmaceutical company, most recently as Senior Vice President and Associate General Counsel. Prior to Pfizer, Mr. Parini was an attorney at Akin, Gump, Strauss, Hauer & Feld, L.L.P. Mr. Parini holds a B.A. from Georgetown University and a J.D. from the Georgetown University Law Center.
As the Executive Vice President and Chief Legal and Administrative Officer of Vertex Pharmaceuticals, the total compensation of Michael Parini at Vertex Pharmaceuticals is $5,372,340. There are 5 executives at Vertex Pharmaceuticals getting paid more, with Jeffrey Leiden having the highest compensation of $18,790,000.
Michael Parini is 44, he's been the Executive Vice President and Chief Legal and Administrative Officer of Vertex Pharmaceuticals since 2017. There are 24 older and no younger executives at Vertex Pharmaceuticals. The oldest executive at Vertex Pharmaceuticals, Inc. is William Young, 75, who is the Independent Director.
Michael's mailing address filed with the SEC is C/O VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVENUE, BOSTON, MA, 02210.
Over the last 21 years, insiders at Vertex Pharmaceuticals have traded over $934,925,905 worth of Vertex Pharmaceuticals stock and bought 308,652 units worth $12,298,449 . The most active insiders traders include Lloyd Carney, Jeffrey M Leiden, and Joshua S Boger. On average, Vertex Pharmaceuticals executives and independent directors trade stock every 5 days with the average trade being worth of $4,747,875. The most recent stock trade was executed by Jeffrey M Leiden on 30 August 2024, trading 3,784 units of VRTX stock currently worth $1,888,216.
Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Vertex Pharmaceuticals executives and other stock owners filed with the SEC include: